By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Lejrvej 37-41

Værløse    DK-3500  Denmark
Phone: 45-44-47-80-80 Fax: 45-44-47-24-25



Company News
Egalet Announces Closing Of $30 Million Public Equity Offering 7/12/2017 8:50:35 AM
Egalet Announces Proposed Public Offering Of Common Stock And Warrants 7/6/2017 7:38:08 AM
Egalet Receives Complete Response Letter From FDA For Prior Approval Supplement For 10 Mg And 15 Mg Dosage Strengths Of OXAYDO 6/20/2017 7:34:00 AM
Egalet Partners with ASCEND Therapeutics, Inc. To Co-Promote SPRIX Nasal Spray 6/7/2017 8:01:00 AM
Egalet Announces ARYMO ER Added To Large Payer Formulary 6/6/2017 8:53:38 AM
Egalet Announces Issuance Of New U.S. Patent For Guardian Technology 6/5/2017 9:06:41 AM
Egalet Announces Results Of ARYMO ER Harm Reduction Modeling Analysis 5/19/2017 6:34:35 AM
Egalet Announces ARYMO ER Data Published In Journal Of Opioid Management And American Journal Of Drug And Alcohol Abuse 5/17/2017 8:11:39 AM
Egalet Reports First Quarter 2017 Financial Results 5/10/2017 11:26:34 AM
Egalet To Report First Quarter 2017 Financial Results During Investor Day On May 10, 2017 In New York 4/26/2017 10:39:32 AM